Compounds having the formula (I), and pharmaceutically acceptable salts thereof,
are useful for modulating mitochondrial F
1
F
0
ATPase activity and treating ischemic conditions including myocardial infarction, congestive heart failure, and cardiac arrhythmias.
具有式(I)的化合物及其药学上可接受的盐,对于调节线粒体F1F0
ATP酶活性和治疗缺血性疾病,包括心肌梗死、充血性心力衰竭和心律失常,具有用途。